CClinicalTrials.gg
CompletedNCT05925855Updated Oct 1, 2026

Effect of Phonophoresis on Trigger Points

An interventional study of US with fastum and US with reparil in Trigger Point Pain, Myofascial, sponsored by Batterjee Medical College. Completed at 1 site in Saudi Arabia. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Batterjee Medical College · Not applicable, Interventional, and Treatment

Updated Oct 1, 2026Enrollment updatedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

purpose of this study was to investigate the effects of phonophoresis with fastum gel versus reparil gel on pain intensity, pain threshold, and cervical ROM of participant with trigger point of upper trapezius.

Read the detailed description

participants will be divided into 3 groups, 2 study groups and 1 control group.

02

Conditions studied

  • Trigger Point Pain, Myofascial
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 66 is close to the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Batterjee Medical College is the lead sponsor of 16 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • upper trapezius trigger point

Exclusion criteria

Exclusion Criteria:

  • cervical disc
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    study Fastum

    participant in this group will receive US with fastum gel

    Other: US with fastum

  • Experimental
    study Reparil

    participant in this group will receive US with reparil gel

    Other: US with reparil

  • Active comparator
    Control plain gel

    participant in this group will receive US with gel

    Other: US with plain gel

Interventions

  • OtherUS with fastum

    apply fastum on trigger point with US

  • OtherUS with reparil

    apply reparil on trigger point with US

  • OtherUS with plain gel

    apply gel on trigger point with US

06

What researchers measure

Primary outcomes

  1. pain intensity

    change of pain intensity by using VAS from 0 to 10

    Time frame: Two weeks and 3 months follow up

  2. pain threshold

    change of pain threshold by using PPA

    Time frame: two weeks and 3 months follow up

  3. ROM

    change of ROM by using CROM

    Time frame: two weeks and 3 months follow up

  4. neck function

    change of neck function by using Neck Disability Index (NDI) questionnaire

    Time frame: Two weeks and 3 months follow up

07

Study locations

1 site
  • Batterjee Medical College
    Jeddah, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No — all data are secured with principle investigator.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Enrollment
20→66
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Enrollment 20→66

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05925855
Lead sponsor
Batterjee Medical College
Responsible party
Reem Dawood (Assistant professor, Batterjee Medical College) — Principal investigator
First posted
Jun 29, 2023
Start date
Jul 1, 2023
Primary completion
Aug 1, 2023
Completion
Dec 30, 2023
Last update
Oct 1, 2026

Study contacts

Osama R Abdelraouf, PhD
study director · Batterjee Medical College

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion